This episode offers an in-depth look at the latest regulatory developments shaping the European Union’s financial and trade landscapes, focusing on Bubills, tokenised finance, trade sanctions, customs enforcement, and indirect CO2 aid (Beihilfe). Notably, the European Central Bank held an emergency meeting addressing a significant cyber threat from the AI system Claude Mythos, urging banks to ramp up cybersecurity and information sharing. The ECB also announced important decisions effective July...
Jun 01, 2026•5 min•Ep. 18
This week's EU Regulatory Updates Covers six developments across AI governance, data protection, climate finance, water risk, clinical trials, and merger control. The European Commission issued draft guidelines helping AI providers and deployers assess whether their systems qualify as high-risk under the EU AI Act — stakeholder feedback open until June 23, 2026. This directly affects all organisations deploying AI in health, safety, or fundamental rights contexts across the European Union. In Fr...
May 25, 2026•4 min•Ep. 17
This episode dives into significant regulatory developments within the European Union, focusing on emerging challenges and policy responses in Artificial Intelligence, cybersecurity vulnerabilities, the European Peace Facility, health screening initiatives, and macroprudential risk management through the SyRB. Notably, the French authorities disclosed multiple critical security vulnerabilities affecting Spring and Cloud Function products, urging organizations to apply necessary patches to mitiga...
May 17, 2026•6 min•Ep. 16
This episode delves into key regulatory topics affecting the European Union, including the gradual reduction of the Asset Purchase Programme by the European Central Bank, recent warnings on the off-label use of Fosphenytoin in children, and a pivotal court ruling on the revocation of EU freedom of movement rights. The European Commission approved the joint control acquisition of Rayner Surgical Group by GBL and CVC, confirming compliance with EU merger regulations and the internal market framewo...
May 11, 2026•5 min•Ep. 15
This episode covers significant regulatory updates across several sectors including Public Health, legal injunctions, cybersecurity measures in banking, monetary policy decisions by the European Central Bank (ECB), and recent rulings by the Verwaltungsgericht Berlin. The ECB maintained its key interest rates unchanged while highlighting inflation risks due to the Middle East conflict and energy price volatility, underscoring its commitment to price stability and readiness to adjust policy instru...
May 04, 2026•5 min•Ep. 14
This episode covers vital regulatory changes impacting the pharmaceutical sector, financial messaging standards, crypto asset warnings, and financial policy oversight within Europe and the UK. We detail France's implementation of a strict qualitative contingentment protocol for Etopophos 100 mg, limiting its use to priority indications and requiring mandatory physician validation for prescriptions. The UK’s Financial Conduct Authority has issued a cautionary notice on Cointrade, an unregistered ...
Apr 27, 2026•6 min•Ep. 13
This episode provides an in-depth review of key regulatory developments impacting sectors such as the ADRA project on veterinary antibiotics, banking supervision enhancements, cybersecurity risks linked to Claude Mythos, market abuse investigations, and antibiotic regulations. The Bank of England has released a comprehensive operational guide on transfer resolution, clarifying governance arrangements and recapitalisation payment mechanisms to improve transparency and firm preparedness. Authoriti...
Apr 20, 2026•4 min•Ep. 12
This episode covers critical regulatory developments across the European Union and the United Kingdom, spanning trading suspensions, financial conduct authority actions, defence sector oversight, employment law reforms, and supervisory notices. Notably, the French AMF confirmed the resumption of trading on RAPID NUTRITION shares following a suspension triggered by suspected 'pump and dump' schemes. Investors are cautioned to remain vigilant against price manipulation while Euronext has cleared a...
Apr 13, 2026•5 min•Ep. 11
This episode delves into recent regulatory developments across insurance, banking internal models, and clinical evaluation procedures within the EU regulatory landscape. The European Central Bank has transitioned from an ex ante to an ex post assessment approach for banks' internal credit risk models, allowing more agile implementation of material changes after internal controls confirm regulatory compliance. This change reduces supervisory workloads and focuses on higher-risk cases with targete...
Apr 06, 2026•4 min•Ep. 10
This episode delivers an in-depth analysis of recent European Union regulatory developments spanning Regulatory Oversight, Basel III financial standards, EUDAMED medical device regulation, European Parliament legislative activities, and cybersecurity challenges. Among the critical updates, the European Medicines Agency’s CHMP endorsed marketing authorisation for Joenja under exceptional circumstances, emphasizing stringent physician oversight for treating activated phosphoinositide 3-kinase delt...
Mar 30, 2026•5 min•Ep. 9
This episode delivers comprehensive insights into EU regulatory developments across electronic product information (ePI), bone complication treatments, Urssaf employment obligations, and monetary policy under the European Central Bank (ECB). The European Union is advancing its ePI initiative with a phased roadmap starting late 2026, initially focusing on vaccines and oncology products before expanding to all centrally authorized medicines by 2028. This transition requires applicants to integrate...
Mar 23, 2026•4 min•Ep. 8
This episode covers significant regulatory updates affecting Olympus medical device recalls, Class III implantable devices, the advancement of small modular reactors in nuclear energy, and the current EU oil supply outlook. A major update includes the urgent field safety notice for Olympus PK, PKS, and Everest cutting forceps due to defective welds posing serious patient safety risks. Healthcare facilities are required to quarantine affected devices and notify Olympus promptly. In nuclear energy...
Mar 16, 2026•5 min•Ep. 7
This episode covers regulatory updates in MiCA, EMIR, Position Limits, Medicines Recall, Catastrophe Naturelle. We begin with the European Commission's strategic support for eastern EU regions bordering Russia, Belarus, and Ukraine, focusing on resilience and sustainable development. In financial regulation, ESMA announces fines and supervisory measures against REGIS-TR for multiple infringements under EMIR and related rules, emphasizing market integrity and investor protection. The AMF has susp...
Mar 15, 2026•7 min•Ep. 7
This episode covers significant regulatory developments impacting sectors such as Primary Residence, Banking Authorization, cVDPV, Polio, and Legal Aid within the European Union. Key updates include France’s revised bonus-malus unemployment insurance rates and the introduction of a mandatory 50 euro online fiscal stamp contribution for civil procedure filings. In Germany, BaFin issues a warning about an unauthorized banking website, unzerfinanzpro.de, urging consumers to avoid engagement. Additi...
Mar 09, 2026•4 min•Ep. 6
This episode explores recent regulatory developments impacting key healthcare and consumer safety sectors including Ulcerative Colitis therapies, medical device safety notifications, risks from falsified medicines, and toy safety concerns. Among the major updates, Philips Respironics issued an urgent field safety notice on the BiPAP A40 Pro device discontinuation due to oxygen sensor alarm issues, requiring physician guidance for continued use or device replacement. Additionally, Erbe Elektromed...
Mar 02, 2026•8 min•Ep. 5
This episode covers regulatory updates in Sanctions, Pump and Dump, Position Limits, Market Abuse, EU Eastern Border. The European Commission has launched a comprehensive strategy to support the EU's eastern border regions adjacent to Russia, Belarus, and Ukraine, focusing on security, economic growth, connectivity, and social support. In financial markets, ESMA has issued public notices regarding significant supervisory measures and fines imposed on REGIS-TR due to multiple regulatory infringem...
Feb 23, 2026•7 min•Ep. 4
Welcome to Carver's European Union Regulatory Updates, featuring the latest in financial regulation, cybersecurity, AI, and digital assets. We begin with ESMA's confirmation of new position limits proposed by Germany’s BaFin affecting the European Energy Exchange’s German Power Base contracts, ensuring market integrity across spot and future months. In France, the Autorité des marchés financiers (AMF) has officially withdrawn APICAP’s portfolio management license following the transfer or cessat...
Feb 17, 2026•4 min•Ep. 3
Welcome to this edition of Carver's European Union Regulatory Updates. This podcast highlights critical institutional developments across the EU's financial regulatory landscape. Key topics include: The joint publication by the European Banking Authority, European Securities and Markets Authority, and European Insurance and Occupational Pensions Authority of informational sheets to protect consumers against AI-enabled online financial fraud. Recent disclosures of cybersecurity vulnerabilities im...
Feb 08, 2026•4 min•Ep. 2
Welcome to Carver’s latest regulatory news update. We begin with the European Union’s new regime governing offers of securities, including transferable and non-transferable debt instruments like mini-bonds and loan notes. The updated framework enhances regulatory oversight to protect consumers from unauthorized offers. Next, the Federal Office of Justice has imposed a disciplinary fine on BayWa Aktiengesellschaft for late electronic submission of its 2024 consolidated accounts, highlighting stri...
Jan 31, 2026•4 min•Ep. 1
